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Abstract
Background: Sm
all cell lung cancer is an aggressive subtype of lung cancer w
hereby about one-third of cases are com
plicated w
ith bra-
in m
etastases. How
ever, cerebellar m
etastases are uncom
m
on and contribute to less than 10%
 of brain m
etastases. Case: W
e report a 
76-year-old M
alay m
ale, an active sm
oker w
ho presented w
ith dyspnea and occasional cough w
ith hem
optysis for one w
eek. He also 
pre sented w
ith headache and constitutional sym
ptom
s of m
alignancy. Clinical exam
ination suggested the presence of right upper chest 
patholo gy and positive left cerebellar signs. His condition deteriorated tw
o days later and he passed aw
ay after failed attem
pts at resus-
citation. Chest radiograph show
ed right upper lobe collapse, and brain m
agnetic resonance im
aging show
ed m
etastatic lesion in the left 
cerebellum
 extending to the right cerebellum
. Post-m
ortem
 findings revealed sm
all cell lung cancer w
ith cerebellar m
etastases. Conclu-
sion: Sm
all cell lung cancer patients w
ith brain m
etastases deteriorate very rapidly, and the m
anagem
ent is m
ainly supportive. Prim
ary 
prevention through education is the best w
ay to reduce the incidence of lung cancer. In addition, secondary prevention and screening 
should be undertaken at earlier stages of the disease, as som
e studies have show
n that com
bined chem
otherapy and radiotherapy im
-
prove prog nosis of m
alignancies detected at early stage.
Keyw
ords: Lung N
eoplasm
s, Sm
all Cell Lung Carcinom
a, N
eoplasm
s M
etastasis, Cerebellar N
eoplasm
s (Source: M
eSH, N
LM
).
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Introduction
Lung cancer can be divided into tw
o types, sm
all cell (SCLC) 
and non-sm
all cell carcinom
as (N
SCLC). 1 SCLC m
akes up about 
20%
 of all lung cancer cases. 1,2 Com
pared to N
SCLC, SCLC has a 
m
ore aggressive disease course and alm
ost alw
ays m
etastasi-
zes to extra-thoracic organs. 2,3 70%
 of patients w
ith SCLC pre-
sent w
ith extra-thoracic m
etastases at the tim
e of diagnosis. 3 
Brain m
etastases are seen in 30.5%
 of patients w
ith SCLC. 1,4 
Cerebellar m
etastases are uncom
m
on and contribute to less 
than 10%
 of brain m
etastases. 1,2,5 
Essentially, the prognosis of the SCLC patient w
ith brain m
etas-
tases is very poor w
ith a m
edian survival of one year. 3,5 One iso-
lated study has reported survival of m
ore than three years fo-
llow
ing intensive com
bination of high dose chem
otherapy and 
radiotherapy. 3 In advanced cases, palliative care is as im
portant 
as chem
otherapy to im
prove the quality of life of the patient. 5
W
e report an advanced case of SCLC w
ith brain m
etastases, the m
a-
nagem
ent of w
hich w
as m
ainly supportive. W
e w
ould like to highli-
ght the im
portance of prim
ary and secondary prevention in the m
a-
nagem
ent of SCLC, as advanced disease carries a poor prognosis. 1,5
W
ritten inform
ed consent w
as obtained from
 both the patient and 
his w
ife to discuss his case in the form
 of a published case report.
The Case
This is a case of a 76-year-old M
alay m
ale farm
er, an active 
sm
oker w
ho started to sm
oke 50 years ago w
ith a 40 pack-
year history. He developed a non-productive cough six m
onths 
prior to hospital adm
ission. Tw
o m
onths later, he developed a 
headache, nausea, vom
iting and loss of appetite. His original 
w
eight w
as 80 kilogram
, of w
hich he lost 15 kilogram
 (or 19%
 of 
his body w
eight). Initially, his daily activity rem
ained norm
al. 
How
ever, one m
onth prior to adm
ission, he developed difficulty 
in m
aintaining his balance w
hile w
alking and becam
e depen-
dent on activities of daily living.
O
ne w
eek prior to adm
ission, he started experiencing dysp-
nea and an exacerbation of his cough. O
n the day of ad-
m
ission, he developed hem
optysis and severe dyspnea, not 
relieved by rest. H
e w
as brought by fam
ily m
em
bers to the 
hospital. O
n arrival, he w
as alert and w
as given oxygen su-
pport via nasal prong at 3L/m
inute. H
e had no sym
ptom
s of 
heart failure, chest pain, fever, history of tuberculosis con-
tact, night sw
eating, history of prolong im
m
obilization, calf 
pain or hem
atem
esis.
The patient has underlying hypertension and hyperlipidem
ia 
diagnosed tw
o years earlier and is on regular follow
-up. H
is 
last follow
-up w
as six m
onths ago and he did not com
plain 
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          Key Points:
• SCLC w
ith cerebellar m
etastases carries poor prognosis.
• The principle of m
anagem
ent is m
ainly palliative than curative.
• Com
bin
ed radioth
erapy an
d ch
em
oth
erapy h
elps to im
prove th
e 
su
rvival rates.
• Prim
ary prevention should be given m
ore em
phasis as prevention is 
better than cure.
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of any problems to his primary care physician. Cardiovas-
cular and respiratory examinations were normal during that 
visit. He is compliant with his medication (perindopril 2mg 
and atorvastatin 20mg daily). He has no family history of 
malignancy.
On physical examination, he was conscious, in pain and in 
respiratory distress. His blood pressure was 130/88mmHg. 
Respiratory examination revealed right upper lung pathology 
evidenced by reduced chest expansion and vesicular breath 
sounds. Bilateral supraclavicular lymph nodes were palpable. 
Cerebellar signs such as dysdiadochokinesia, positive finger 
nose test and heel shin test were present and predominantly 
affected the left side of his body. Examinations of other sys-
tems were unremarkable.
A series of investigations were completed. Arterial blood gas 
(ABG) demonstrated type I respiratory failure with PaO2 of 
53mmHg. A full blood count and liver function tests were nor-
mal. Blood urea and serum electrolyte showed a slight ele-
vation of serum urea and creatinine. The chest radiograph 
revealed a right upper lobe collapse with loss of pulmonary 
vascular markings (Figure 1). T2-weighted MRI displayed a sin-
gle ill-defined hyperintense lesion measuring 6 x 5 cm in the 
left cerebellum extending to the right cerebellum (Figure 2). 
His electrocardiography (ECG) showed sinus rhythm and was 
normal. Tuberculosis work-ups, including a Mantoux test and 
sputum acid-fast bacilli were negative.
Bronchoscopy was performed and demonstrated the presence 
of a mass in the right main bronchus measuring 5 x 3 cm. 
Biopsy confirmed small cell lung cancer (SCLC) as the histologi-
cal diagnosis (Figure 3). Computerized Tomography (CT) scan of 
the thorax was not completed, as the service was not available 
at that time. Based on the examination findings, bronchoscopy 
and MRI, he was diagnosed with stage IV (T2N3M1) SCLC with 
cerebellar metastases. 
The possible differential diagnoses included pulmonary and 
cerebellar tuberculosis, pulmonary embolism, stroke and 
myocardial infarction. Tuberculosis is common in Malaysia, 
however he denied any night sweats, tuberculosis contact 
and tuberculosis work-ups were negative. Pulmonary em-
bolism was possible, but he did not complain of pleuritic 
chest pain or have a history of immobilization. Stroke and 
myocardial infarction were possible based on his risk fac-
tors, such as male gender, old age, smoking, hypertension 
and hyperlipidemia, but the progressive onset of the di-
sease made this unlikely. In addition, the ECG ruled out 
ischemic changes. Therefore, the most likely provisional 
diagnosis at this point was right lung cancer with cerebellar 
metastases. 
He was admitted to the respiratory care unit and given oxygen 
support via oxygen mask at 9L/minute. He was also given 
intravenous morphine 10mg daily dose for pain relief and 
intravenous pantoprazole 20mg twice daily dose to prevent 
gastric ulcers. 
He was scheduled for palliative combined chemotherapy and 
radiotherapy. He was counseled on the disease burden and 
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Figure 1. Posterior-Anterior (PA) View Chest Radiograph.
Legend: Figure 1 shows a right upper lobe collapse (red arrow) with loss of pul-
monary vascular markings. The trachea also deviated towards the right side.
Figure 2. T2-weighted MRI of the Patient.
Legend: Figure 2 showes a single ill-defined hyperintense lesion (red arrows) 
measuring 6 x 5 cm in the left cerebellum extending to the right cerebellum. 
The lesion was surrounded by hypointense area suggestive of brain edema.
Figure 3. Higher Magnification of the Small Cell Lung Cancer 
Showing Numerous Mitotic Figures (red arrows).
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Int J Med Students   •   2015  |  2014 Nov-2015 Mar  |  Vol  3  |  Issue 1 The International Journal of Medical Students 57
the long term complications of the treatment. He understood 
and agreed to the treatment plan. The chemotherapy regimens 
included intravenous cisplatin 60-80mg/m2 on day 1 for every 
28 days and intravenous etoposide 80-120mg/m2 on days 1 to 
3 for every 28 days. Palliative low dose radiotherapy of about 
20-30Gy was scheduled to be given in 5 to 10 fractions. Surgery 
was not indicated as the disease had already progressed to an 
advanced stage. 
However, these therapies were not given because his condition 
rapidly deteriorated two days later. He collapsed suddenly, was 
intubated and given mechanical ventilation. Due to the sudden 
nature of his collapse, consent from the patient himself was 
not obtained for resuscitation. The decision to intubate was 
made after a discussion with family members. He was given in-
travenous adrenaline 1mg every five minutes. He passed away 
after failed cardio-pulmonary resuscitation (CPR) for 30 minu-
tes. He was sent for post-mortem examination and autopsy 
confirmed that he had small cell lung carcinoma arising from 
right main bronchus with cerebellar metastases.
Discussion
The rapid progression of SCLC that has metastasized to the 
brain has been well documented in the literature.1,5 Case re-
ports report that patients may survive for three to five, after 
being treated with a combined chemotherapy and radiotherapy 
regimen.2,3
A systemic review and meta-analysis concluded that first line 
treatment for advanced SCLC should include four to six cycles 
of etoposide in addition to either cisplatin or carboplatin.6 Oral 
or intravenous topotecan is recommended for patients that are 
resistant to first line treatments.6 However, the routine use of 
thoracic irradiation in patients with metastatic SCLC is not re-
commended.6 The optimal surveillance of metastatic disease 
involves 3-monthly CT scans to monitor disease progression 
and response to treatment.6
A randomized control study showed that thoracic radiotherapy 
in addition to prophylactic cranial irradiation improved survival 
rates in the thoracic radiotherapy group than in the control 
group.7 However, Hirofumi Sakurai and et al., described two 
cases of SCLC with no metastatic lesions, where patients were 
started on early chemo radiotherapy and metastates were de-
tected one and a half years later.8 This draws a question as 
to whether early treatment will benefit the patient. Generally, 
most of literature still supports early detection and treatment 
to reduce morbidity and mortality.1,2,5-7
The majority of published case studies only discuss the bene-
fit of early detection and treatment.1,2,7 However, there is still 
a need for case reports which discuss a standardized mana-
gement of advanced SCLC with brain metastases. Some case 
reports highlight the role of gamma knife surgery and intra-
cranial irradiation in advanced disease to prolong the survi-
val rate.9,10 However, most patients do not easily accept brain 
surgery and irradiation because of concerns of intra-operative 
complications and post-operative intellectual reduction.7 As 
for chemotherapy regimens, combination of cisplatin and eto-
poside are usually used although it still has limited proven 
efficacy in preventing metastatic disease.7,8 All these factors 
contribute to the limited success rate in the treatment of ad-
vanced SCLC.8
Conclusion
In conclusion, the rapid progression of advanced SCLC has po-
ses many difficulties to clinicians treating this cohort of pa-
tients. Although there is no definitive treatment for advanced 
SCLC, we would like to stress the benefits of prevention and 
early detection.11,14 Attention should be drawn towards smo-
king as one of the most important contributors in the patho-
genesis of lung cancer.12,13 Primary prevention by education on 
smoking cessation should be implemented and enhanced in 
the healthcare system.13-15 Images of lung cancer and obste-
tric complications caused by smoking have been printed on 
cigarette packing of many countries to discourage smoking.14 
A study has shown that public education on tobacco smoking 
is still very low and public education campaigns are needed 
urgently to raise the public awareness on the harmful effects of 
tobacco products.16 Secondary prevention, which includes lung 
cancer screening among active and past smokers, should be 
encouraged for early disease detection.13,17 Tertiary prevention 
has limited role in treating advanced lung cancer.2,5 Therefore, 
prevention is always better than cure!
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